Clinical Trial Detail

NCT ID NCT03929666
Title A Safety and Efficacy Study of ZW25 Plus Combination Chemotherapy in HER2-expressing Gastroesophageal Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Zymeworks Inc.
Indications

gastroesophageal adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + ZW25

Cisplatin + Fluorouracil + Leucovorin + ZW25

Capecitabine + Cisplatin + ZW25

Age Groups: adult senior

Additional content available in CKB BOOST